Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
RadiOnCOVID: Multicentric Analysis of the Impact of COVID-19 on Patients Undergoing Radiation Therapy in Italy.
Guerini AE, Marvaso G, Tonoli S, Corrao G, Teriaca MA, Sepulcri M, Scricciolo M, Gava A, Montrone S, Giaj-Levra N, Chiorda BN, Mantello G, Fiorica F, Borghesi S, Belgioia L, Caroli A, Fiorentino A, Radioncovid Study Group, Jereczek-Fossa BA, Magrini SM, Buglione M. Guerini AE, et al. Among authors: buglione m. Cancers (Basel). 2024 Dec 30;17(1):86. doi: 10.3390/cancers17010086. Cancers (Basel). 2024. PMID: 39796715 Free PMC article.
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment.
Guerini AE, Tucci A, Alongi F, Mataj E, Belotti A, Borghetti P, Triggiani L, Pegurri L, Pedretti S, Bonù M, Tomasini D, Imbrescia J, Donofrio A, Facheris G, Singh N, Volpi G, Tomasi C, Magrini SM, Spiazzi L, Buglione M. Guerini AE, et al. Among authors: buglione m. Cancers (Basel). 2022 May 2;14(9):2273. doi: 10.3390/cancers14092273. Cancers (Basel). 2022. PMID: 35565401 Free PMC article.
Cetuximab and Radiation Therapy in Head and Neck Cancer.
Maddalo M, Triggiani L, Magrini SM Prof, Buglione M. Maddalo M, et al. Among authors: buglione m. Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):678-679. doi: 10.1016/j.ijrobp.2019.07.025. Int J Radiat Oncol Biol Phys. 2019. PMID: 31540600 No abstract available.
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients.
Guerini AE, Pedretti S, Salah E, Simoncini EL, Maddalo M, Pegurri L, Pedersini R, Vassalli L, Pasinetti N, Peretto G, Triggiani L, Costantino G, Figlia V, Alongi F, Magrini SM, Buglione M. Guerini AE, et al. Among authors: buglione m. Sci Rep. 2020 Aug 12;10(1):13589. doi: 10.1038/s41598-020-70430-2. Sci Rep. 2020. PMID: 32788596 Free PMC article.
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients.
Buglione M, Alterio D, Maddalo M, Greco D, Gerardi MA, Tomasini D, Pegurri L, Augugliaro M, Marvaso G, Turturici I, Guerini A, Ansarin M, Spiazzi L, Costa L, Cossu Rocca M, Magrini SM, Jereczek-Fossa BA. Buglione M, et al. Radiat Oncol. 2021 Dec 20;16(1):239. doi: 10.1186/s13014-021-01966-4. Radiat Oncol. 2021. PMID: 34930353 Free PMC article.
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.
Buglione M, Maddalo M, Corvò R, Pirtoli L, Paiar F, Lastrucci L, Stefanacci M, Belgioia L, Crociani M, Vecchio S, Bonomo P, Bertocci S, Borghetti P, Pasinetti N, Triggiani L, Costa L, Tonoli S, Grisanti S, Magrini SM. Buglione M, et al. Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):462-472. doi: 10.1016/j.ijrobp.2016.10.011. Epub 2016 Oct 20. Int J Radiat Oncol Biol Phys. 2017. PMID: 27986347 Clinical Trial.
147 results